---
title: "Clinigen Pharma Limited — Ownership Dossier"
canonical: https://whiteintel.dev/entity/8bb575fc-a5ec-552e-b42d-dcd28c5b25af
json: https://whiteintel.dev/api/public/dossier/8bb575fc-a5ec-552e-b42d-dcd28c5b25af
identifier: oo:GB-COH-07869194
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Clinigen Pharma Limited

**Type:** Company  
**Jurisdiction:** GB  
**Identifier:** `oo:GB-COH-07869194`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/8bb575fc-a5ec-552e-b42d-dcd28c5b25af  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/8bb575fc-a5ec-552e-b42d-dcd28c5b25af  

## Ownership & control

### Owners / controllers

- **CLINIGEN HEALTHCARE LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/427ada07-4794-569a-922a-0dd9fa49e517
- **Clinigen Pharma Limited** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/2505da54-2352-46bf-930c-045990188d75

### UBO chain (walk to the ultimate owner)

1. **CLINIGEN HEALTHCARE LIMITED** — beneficial owner 87.5% → *Clinigen Pharma Limited*
1. **Clinigen Pharma Limited** — beneficial owner 87.5% → *Clinigen Pharma Limited*
2. **Clinigen Group Plc** — beneficial owner 87.5% → *CLINIGEN HEALTHCARE LIMITED*
2. **Clinigen Holdings Limited** — beneficial owner 87.5% → *CLINIGEN HEALTHCARE LIMITED*

## Company profile (live · UK Companies House)

- **Company number:** `07869194`
- **Status:** dissolved
- **Type:** ltd
- **Incorporated:** 2011-12-02
- **Registered office:** Pitcairn House Crown Square, Centrum 100, Burton-On-Trent, Staffordshire, DE14 2WW
- **SIC:** 99999

### Officers

- PALING, Richard John — director · British · appointed 2021-08-24
- ABELL, Martin James — secretary · appointed 2017-03-02 · resigned 2017-07-13
- HADDLETON, James Sidney — secretary · appointed 2015-11-02 · resigned 2017-03-02
- MILLER, Amanda — secretary · appointed 2017-07-13 · resigned 2023-01-16
- SIBSON, Robin Andrew John — secretary · appointed 2011-12-02 · resigned 2015-11-02
- ABELL, Martin James — director · British · appointed 2015-12-01 · resigned 2019-03-19
- CHILTON, Shaun Edward — director · British · appointed 2014-04-01 · resigned 2022-10-14
- GEORGE, Peter Lutz — director · British · appointed 2012-02-14 · resigned 2016-11-11
- GEORGE, Peter Lutz — director · British · appointed 2011-12-02 · resigned 2012-02-14
- KEHER, Nicholas Patrick — director · British · appointed 2019-03-19 · resigned 2021-08-24
- SIBSON, Robin Andrew John — director · British · appointed 2011-12-02 · resigned 2015-12-02

### Beneficial owners (Persons with Significant Control)

- Clinigen Pharma Limited — 75–100% shares · corporate PSC · England — since 2017-06-28
- [Clinigen Healthcare Limited](https://whiteintel.dev/entity/427ada07-4794-569a-922a-0dd9fa49e517) — 75–100% shares · corporate PSC · England — ceased 2017-06-28

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/07869194

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Clinigen Pharma Limited**. Human view: https://whiteintel.dev/entity/8bb575fc-a5ec-552e-b42d-dcd28c5b25af · Structured JSON: https://whiteintel.dev/api/public/dossier/8bb575fc-a5ec-552e-b42d-dcd28c5b25af._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._